Waldenström's Macroglobulinemia
What is Waldenström's Macroglobulinemia?
Waldenström's macroglobulinemia is a rare type of non-Hodgkin lymphoma. It affects white blood cells called B lymphocytes. These cells normally help your immune system fight infections.
In this condition, abnormal B cells grow out of control in your bone marrow. They produce large amounts of an abnormal protein called immunoglobulin M, or IgM. This protein makes your blood thicker than normal. It can interfere with blood flow and organ function.
Waldenström's macroglobulinemia is a slow-growing cancer. Most people live for many years after diagnosis. Treatment focuses on managing symptoms and slowing disease progression. Many people have no symptoms for years and do not need immediate treatment.
Symptoms
- Fatigue and weakness that does not improve with rest
- Easy bruising or bleeding from the nose or gums
- Numbness or tingling in hands and feet
- Swollen lymph nodes in the neck, armpits, or groin
- Unexplained weight loss over several months
- Enlarged spleen causing abdominal discomfort
- Vision problems or blurred vision
- Frequent infections due to weakened immunity
- Headaches or dizziness
Many people have no symptoms when first diagnosed. The condition is often found during routine blood tests. Symptoms typically appear gradually as abnormal protein levels increase.
Concerned about Waldenström's Macroglobulinemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The exact cause of Waldenström's macroglobulinemia is not fully understood. It happens when genetic changes occur in B lymphocytes. These changes cause the cells to multiply uncontrollably. The condition is not inherited and cannot be passed from person to person.
Risk factors include being over age 60, being male, and having a family history of the condition. People with certain autoimmune diseases may have slightly higher risk. White people are more commonly affected than other racial groups. Exposure to certain chemicals or viruses may play a role, but research is ongoing.
How it's diagnosed
Diagnosis begins with blood tests that check for abnormal proteins and blood cell counts. A test called serum protein electrophoresis can detect abnormal protein bands. Immunofixation testing identifies the specific type of abnormal protein. Your doctor will also measure your IgM antibody levels.
A bone marrow biopsy is usually needed to confirm the diagnosis. This test examines cells from your bone marrow under a microscope. Imaging tests like CT scans may check for enlarged organs or lymph nodes. Talk to your doctor about specialized testing if you have symptoms or abnormal blood test results.
Treatment options
- Active monitoring with regular blood tests if you have no symptoms
- Chemotherapy medications to slow cancer cell growth
- Targeted therapy drugs that attack specific proteins on cancer cells
- Immunotherapy to help your immune system fight cancer cells
- Plasmapheresis to remove excess protein from your blood
- Stem cell transplant in certain cases for younger patients
- Managing infections promptly with antibiotics when needed
- Staying active and eating a nutrient-rich diet to support overall health
- Avoiding extreme cold, which can worsen symptoms in some people
Frequently asked questions
Waldenström's macroglobulinemia is a rare blood cancer affecting B lymphocytes in your bone marrow. These abnormal cells produce too much of a protein called IgM. This makes your blood thicker and can affect multiple organs. It is a slow-growing cancer that many people live with for years.
Many people have no early symptoms and are diagnosed through routine blood work. When symptoms appear, they often include fatigue, weakness, and easy bruising. Some people experience numbness in their hands and feet. Swollen lymph nodes or an enlarged spleen may also occur.
Diagnosis requires blood tests that detect abnormal proteins and low blood cell counts. A bone marrow biopsy confirms the presence of abnormal B lymphocytes. Your doctor will measure IgM levels and check for specific protein patterns. Additional tests may include imaging scans to check organ size.
There is currently no cure for Waldenström's macroglobulinemia. However, it is a slow-growing condition that can be managed for many years. Treatment focuses on controlling symptoms and slowing disease progression. Many people live long, active lives with proper medical care.
Not everyone needs immediate treatment. If you have no symptoms and stable blood counts, your doctor may recommend active monitoring. Treatment typically begins when symptoms develop or blood counts decline. This approach is called watchful waiting and is common for slow-growing cancers.
Serum protein electrophoresis can detect abnormal protein bands in your blood. Immunofixation identifies the specific type of abnormal protein. Your doctor will measure IgM levels and check complete blood counts. Beta-2 microglobulin levels may also be tested to assess disease activity.
While lifestyle changes cannot cure the condition, they support overall health during treatment. Eating a balanced diet rich in vegetables, fruits, and lean proteins helps maintain strength. Regular gentle exercise can reduce fatigue. Avoiding extreme cold is important, as it can worsen symptoms in some people.
Treatment options include chemotherapy drugs that slow cancer cell growth. Targeted therapy medications like ibrutinib block signals cancer cells need to survive. Immunotherapy drugs help your immune system recognize and attack cancer cells. Your doctor will recommend treatment based on your specific situation and symptoms.
The condition is not directly inherited from your parents. However, having a close family member with the condition does increase your risk slightly. Most cases occur without any family history. Genetic changes that cause the condition happen during your lifetime, not at birth.
Testing frequency depends on your treatment status and symptoms. People on watchful waiting typically have blood tests every three to six months. Those receiving treatment may need monthly or quarterly testing. Your doctor will create a monitoring schedule based on your individual needs and response to treatment.